ࡱ> &Root Entry ;@>-@#FileHeader}DocInfoa HwpSummaryInformation.Y*),+./0123456789:;<=>@ABCDEFGHIJKRoot Entry ;@>@#FileHeader}DocInfoa HwpSummaryInformation.Y  !"#$%'1(: Biopharmaceutical Basics <|><><Yյ´><P> <12. 20.() $ 3 hr><}t$ư ><% }t$ưX ֬@ >< (1 hr)><t$X}ň ܭ><% ܭX DՔ1  ( ܭ; }Ŭ h % t$X}ňX X, 1,  X % < HP! (BSL 1~4)><@xܭ (2 hr)> <><$ƬLtX> <12. 20.() $ 4 hr><   Analysis of Genetic Information><% Fragmenting DNA; Cloning DNA fragments % Sequencing DNA; Sequencing genomes % Finding the genes in genomes % Genome architecture & evolution><8֠ (4 hr)> <12. 21.(T) $ 3 hr><pi 1 Production of Recombinant Proteins><% LѬDX xƘ1 Heterologous protein production in bacterial hosts u8X xƘ1 Heterologous protein production in eukaryotic cells % 1 Y Protein engineering><8֠ (3 hr)> <12. 21.(T) $ 4 hr><8X How Cells Grow><% ք Batch growth % QX ɷT Quantifying growth kinetics % ō 0X 8 Cell growth in continuous culture><Mօ (4 hr)> <12. 22.() $ 3 hr><mմX}ň u0 Core Technologies of Antibody Therapeutics><% mմ X̸: mմ p Ab fragments % ȴ 8t mմ full-length Abs % CDR  0 % 2 ijTx>GIF89aɻxxxkkk]]]PPPCCC555((( d`LH00`Hذ̘`H0|pdXL@`0H `H0`dHL`H0xp`XH@0d LȰ``HH00dLؘȀ`H0xp`XH@d0L `H0d`LH`H0|pdXL@0`$H`dHL00`HذȘdL0xp`XH@0` HdH0ȳ``HHdL0xp`XH@`0H Ը̰ĠऀؘpȈXxHp@h@d8`8X0xT0pH dxddxd`d`p`|``x`p``x`!, H*\ȰÇ#JHŋ3jȱǏ CIɓ(S\ɲ˗0cʜI͛8sɳϟ@ JѣH*]ʴ)EH:*TWR%u+V0FڵTSɞ]ڵ`WJչxe֬L*^̸ǐ#K~˘bޜ͖?zӞK^ ̕S[֜Y ^6}{ݼ9[?V~5ՊCmزs+{9w᭿G{WLWسXVVvՕVGWE`_Ey u~AZ U^a HD+&"W,FD! FWC4jşH9cb&BߐD7z$^#UX(VC?r".%m9$"ءI #zA җ59q2ҩ )QzZy'WJ(hbF9g&_Rv93~He^6bX&sBhqᣙv-'JfZ殀9a{%8뢆X>T.9{izk.{lFDR[,b) #a%/Һ*ɂK/d0 70c$z BFhwj$\ɘh )q Ep>1qv)}zIte%):,͚^6+r *=oϥLn]QDjo:P/Z*OOrr{̗NS}#>,ksv*Ĵ:RVyPܷGo(ـ\)9!_ ;بרӎO7<|k[5+졃;Md\dUV; U4jk™:ݪ4mDC,:$p8 n|a^x=(Ti"7Ļ!P_X[-=!#Qqm"V87eض ĥ%5C;o}UpE?PB<"hBDdZ(iVwd&h6qAuדGj%yLH®\,6fE[b,(@*Moa H<&!Yer2|HLy-p $dH5"D%YT#S4)t|;.hdd+)ˁ6*N*(-0>/_zJ&-lY&avhLڕ{ҎdA};(xLV,&:3CCiOT+TXxkjTIժBҔKլzu3L4+-y;5m+TS3KVBs0)15)g Wz(zѹu߸GIt{j+D*к̚B(zY:FZ?eĚzШZ9+W88rUhU1SQjߵI]-["q=U|+Z9WJ5cK<XݪZ)D}2l zݛK0Ꭺ_Y kg`B%jMr* ]#n5Efsr +u01Y&r;du3VW/Yn\f9 ELe::̭I\&OX.q/Lgm) fJhJ򽤴?aU8n s6f/o%c}?זΖz+yĽԝ&gr-8ךl ,r,;o&b{iq1fu3l%V9WljϯV('DRgKS[f4G[7b 2vA21.}l{a7hN%:U/;bͭ-{t;rd+EͲic$zUWY]-9\_zɂvU|lG{>X0\ީVU+&o+mY,7~zJt_f7OZm-M[\QZY&^ɉ[\p#H][?k=9nߖP{OHmww^/oU_Nu}JDĚysWH:[:yv :q]>9ѓ/PvϢY}ȧ|m8gEn|Tg}lgYSg3nwZUP'sf2[!W6w\7rCW\4Wv3r{ kQ'?7t𧃇XvjkܥN66oǁh7Qn}FaC#$ps@UX+b(mAjqsDl!OT腘wJ^'c[PS;o,wA~#5y33ACaYrSppXw0{2a\HA#8F~>wkMs7Wn0Yf$_=w~jnw^?TD[Qv&Պ|vZ5/bxV?#؁r8XZvC6oLJy2qg8ZehvHrh^wvG٨ZQq. 9Yyّ "9$Y&y(*,ْ.0y;`a`0x`a``a`0x  x  admin2021D 11 23| T֔| $ 3:58:52organ-9, 1, 1, 3259 WIN32LEWindows_Unknown_Version@`7@ /@>@hI! [b# OAǿ3ZT~ 171 EOQ'Ј hIi8" F=< 8pAfwlRF"ۙv8rEmԩJse{/ǨEmCۋ]+%bH@&r#` I\483$l4Mi]D Bf\ef 17vk(c:=u5lw7vpm,٢g!9^dIQ pU\߉:ommm"IQ}VFcRax*7mo?v4rAƖWBU4c+J",}%8Y3˯{7bqipJ[Z٪tHͧ#fkJXz֧l;aF K'Ej)-ZdƑ`R%)$Bh24wn#}+I!2B#4p? %UTdrH.qdM+ڔEO5h&~JmjAgoONx;ݜNm5 Je H*(89}ʩp'($~]xGNtCMpI8r=ߤf68l&m:@4F&h@Ĥm&@&9[dmKL\U?`0VNю (V>eʂEPCSvRk⢋Yt.ֈ:U1aEKRņԱ1TE,ȍ߹>̹9wq'ج코-R./krLR蓈g=)|ƻdEgW.˦M{6,tlHg+1SZIT,KzҳV.\NHhJi}r ̽ȼC GD<+|bTR#&ϕI33=ubL)\pGw EVx\Xfvۙ\+/0rTyV45ل'>6NWD󬕲⚶87u"gK/SG^dg˖e6ߑ,lVș+{/F'vYXs%eBjϮȍQBZ*s9aBzgWbD=[f։M=Fd#T. ۪ؖt$l7vDe0 smzX8fөi\~,X0վ9SZ㛁jM NRqD{Gnofp}ӐG$<Mօ (4 hr)> <12. 22.() $ 3 hr><mմX}ň u0 Core Technologies of Antibody Therapeutics><% mմ X̸: mմ p Ab fragments % ȴ 8t mմ full-length Abs % CDR  0 % 2 ijTx>BodyText 0/@>`K0@>PrvImage PrvTextDocOptions ;@> ;@>Scripts ;@> ;@>JScriptVersion DefaultJScript_LinkDoc Section0s̗AhUtn4&cM0n,a&*Yq6BLB#+Tz xIPv%JM[!S5A*fz!XޛٙY=8~{;Cȱ7_rc"=up:'gN;Mǧcoa` xo=I,ԚVό#ȩQ:(:0M ɲU #(Iq(o2| uzwy}>lOE)x|:wN61O,źv[ÎeDɰVd#fp9,t>ft& gn0@u.ǹo#oWWW3O_a}1kM{d w wr4zuTgÐ$_McHhԜZj@nФ%SyIn:fNY0H˶a60S^nk7._tQJqH!I2ܶ$KUJW7:jT$kvd7'X}$K kDQǽA;nBB3toC:QoJY4 UNl*Se~ ~ ~#j=Gq %쇬 95wNw2ƫ{o 傐G z>U{Vfxhf oVͤRHmIWMhGV8MB*%vBBlbrrc@Stp顉eQ,cK}(B\>$7%ඨ +Z) t39$kWZYre*4;3o@)`sԳU18n]&BQ$kZY*a@=cԖq(;S<"Tty8{j镭@w|a㭋q놇0)xw*V-rGJ9"&3PG*k[9 !W'B=@Xss bh! ?:\;ؔ5D ּTM-.uMtq^^?̨%쓬dF!A]gt'v)z3G6G}oٸu i0i܇rTt|o[,T5k dzm0YXz~oJ,؊cJck麗Ґ>Ncү4Nˈӳ h5gf)YrV~a  OȱOiÕ egHg3ς/ t[jdoOx-_ =ߎ OAn)Ѫ{h x0I0AIKb CzQшfi֛hlbIL4ftw۩iv +*y\]4JXIh=N{fo]z-6m4)g3' _0r `IZ`H୷s5y;:bW=3dpDFKvTX: $AW-o T)Ko&LaFJπ940Y}F#s6Xz? dpGp:i|#~"p"/EV!Q'"'ht) qR aIh$7h$UE43<}OAO%mg05f˒zry[5&b#Wl #we mI?-4i`z(I8 FkM|GG]f(Cu7o޸,QV6mDU]+@h76Aà=9:S|V7O}+z2yOkVE>mey[kiع~&[u3yƅjA9kA.+M45;,WM ` 0zP"zՏ/2_^ݐ,~~> aRh{35;-Vy Y! WRXm] ʤ`/,N%)H9P_au6)wv6n&ۭFjZh IJ}0HԢYlL6Da|)BR"IS؊`"" yYZ"w? 3ws={ u -T&0DI^'o')nst4ei\h#*MX-C1qQgh7V Z=~r$}rZv <{(ůnH:n-Qd'dZNFaA%HX&zt5'h[|^b2Z}}rC25IF0CCT#'!p,3hghE)O`` f;$~9vryˇYZ"@N01OC4f9z2%AƋ&-,!6Pk3_ !w+O0o`Ppw ƗU*iWN_VNPe_[}l@EҼ~uZ0ZX8Ҟ@o#EY@\03Ʊ㷘I%@5ik m Ek{Y79ǜԛu˚6[YQ*YByh́BmD͖zPN)]W~D;$1ߎdH NTNzKǐEA 6[`kLT3FsQS{X_"N̍^/1]1dd4ǯzɰE&Jf^r/*}P"T^Bl3sn#tW>;3Ab'mWzTClȎ&J獊2ʊ>m5"V4"_ĶR+[M]'~QuR3bΕ9WUve=#{ߞ9~^|=Koz.65[Ĕ|fKoy$%CFfH{1L~WuX&CP@-Chw8QXa+j%laUQTgf^igTy&gv̉W8oxD[=K#VxuPpj_ލF~zp+uPp=gfܣ9?WMkA~v7"FC -ԏ<֦jVX)sOB5NVmNy=϶ҙe ]Ł7 Iܢ}jROz,^jxAPқ }F, ]+ػ|2u$"&IQ5 B).3$3'2h|(=9*D(ʗԺCRL, fLӞr\QrӁe Aj%A:lN˜W p#pA_ . yplqg'>›0a5Zʱ2!<޴+}|k?%%^0-`V.\,uGODa[hx8 ˫-:#=ix ފe>/؋,C\Vx}R!}UgD2:fIYNo3.E ,{.(3ӠV;a7mGy."v/!jqe+Ӯxk^}@ N"4׃iw ?Xu y?VR^RbŜ:&ȉIRs2 xUޗtJ%WMLA}YOb&*^U( JIIA[^9z1(cbbbzԃٓ'E v.n4l27+pg)$Y6MXnM#1=#[ xd( љk(HSYd]SLҌQX$UoczqaX1"H,55"D*zxw i$$OIMBBQpd78KlYJ#Wˊ^H o٤m؎tkzK["^2a/Z&]] c (q Ǘ빗yx_/%Ic5깋VDP dT)ovRnHyVt? qh4kvhfn/u7l傢YJ  @VOV0i 6F`T]cڷGipJk,֔]2EJhqIeIiřp:Kllom d]F{aQbӟYĠ"AkK~EUewb]SR59N'msnDI %P$,{6^3ђfg`88q40@ټ@ < F z @Zc& Į<L0Z!/PD*zGDf.Fc,'@6)0d0c+~;<8>0T420GJpC% "{J8^{JqI 1Auܬ8tǁDPec:vU+'N2]4G͉ŒLA6`Ni9VߤqX+2 &U&IX$1Ynt.@yoa8М8o:i-@"(N`m {qY q`/d !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXZ[\]^_`bcdefghijklmnopqrstuvwxyz{|~